Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index

International Urology and Nephrology

Volumn 32, Issue 3, 2001, Pages 433-436

  Gül, Osman ^a   Eroğlu, Muzaffer ^a   Özok, Uğur ^a  

^a Social Insurance Organization Specialization Hospital   (Turkey)

Author keywords

Prostatitis; Terazosine

Indexed keywords

PLACEBO; TERAZOSIN;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT; ORTHOSTATIC HYPOTENSION; OUTPATIENT CARE; PELVIS PAIN SYNDROME; PRESCRIPTION; PROSTATE DISEASE; PROSTATITIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING; UROLOGY;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; CHRONIC DISEASE; HUMANS; MALE; MIDDLE AGED; PRAZOSIN; PROSTATITIS; TREATMENT OUTCOME;

EID: 0034856442     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017504830834     Document Type: Article

References (7)

1. Prostatitis and related disorders
2. Research guidelines for chronic prostatitis: Consensus report from the first national prostatitis collaborative network
3. Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis
4. Distinguishing chronic prostatitis and benign prostatic hyperplasia symptoms: Results of a national survey of physician visits
5. Diagnosis and treatment of 409 patients with prostatitis syndromes
6. Use of terazosin in prostatodynia and validation of a symptom score questionnaire
7. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: A double-blind, placebo-controlled pilot study